BFM
CASC

Boothbay Fund Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Boothbay Fund Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,187
Closed -$42K – 877
2017
Q1 		$42K Buy
+10,187
New +$42K 0.01% 615